Back

Systolic blood pressure time in target range and cardiovascular disease and premature death

2 September 2024 (09:00 - 09:50)
Organised by: Logo
Congress Presentation Part of: Cardiovascular risk: lessons from epidemiology Epidemiology ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Mr Xu Han

Tianjin (China)

7 More presentations in this session

Presentation thumbnail
High-sensitivity C-reactive protein is associated with cardiac dysfunction and morbidity in a community-based cohort
Doctor M. Sengelov (Hellerup, DK)
Abstract Slides Video
Presentation thumbnail
Associations of omega-3 fatty acid subclasses with cardiovascular diseases in 500,000 individuals
Doctor J. Barrett (Helsinki, FI)
Abstract Slides Video
Presentation thumbnail
An epidemiological update on infective endocarditis: a two-decade retrospective longitudinal analysis
Doctor K. Madan (London, GB)
Abstract Slides Video
Presentation thumbnail
Cardiometabolic multimorbidity and associated risk factors in a cohort identified through community-based screening in Eastern Nepal.
Doctor S. Sharma (Dharan, NP)
Abstract Slides Video
Presentation thumbnail
Association of cumulative systolic blood pressure load with cardiovascular events in patients undergoing percutaneous coronary intervention
Assistant Professor B. Kim (Guri, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular risk: lessons from epidemiology

The Event

Event poster

ESC Congress 2024

2 September 2024 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Relationship between time in systolic target range during 24-hour ambulatory blood pressure monitoring and mortality
thumbnail
Congress Presentation
Association of systolic blood pressure time in target range with heart failure risk and mediating roles of NT-proBNP, hs-cTnI, and eGFR: novel findings from the SPRINT trial
thumbnail
Congress Presentation
Association of different timepoint and threshold of time-in-target-range and MACEs: insight from the SPRINT study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources